ContactISSN:e-ISSN: 2757-976X
Author Sign-inReviewer Sign-inRegister
TürkçeEnglish
Home
About Journal
Copyright NoticeOpen Access PolicyAim and ScopePrinciples of ArbitrationReviewer and Editor GuideFee PolicyEthical Principles and Publication PolicyArchiving PolicyIndexing
Information For AuthorsEditorial BoardSend ArticleLatest IssueArchiveContact Us

E.Coli Frequency and Antibiotic Resistance in Urinary Tract Infections: A Systematic Review

FATMA NUR AYDIN,MEHMET ÖZDEMİR

  • FATMA NUR AYDIN: Necmettin Erbakan Üniversitesi Tıp Fakültesi
  • MEHMET ÖZDEMİR: NECMETTİN ERBAKAN ÜNİVERSİTESİ
  •  Year : 2024
  •  Vol : 4
  •  Issue : 3
  •  Page : 143-147
Purpose: Urinary tract infections are a significant public health issue and the most common cause is E. coli. The compiled articles aim to investigate increasing antibiotic resistance and create awareness and provide an effective treatment path.
Method: Studies on E. coli and antibiotic resistance in the last 5 years were scanned in the Tr Index. Among the open access articles published in 2018 and later, written in Turkish, 13 articles discussing E. coli and antibiotic resistance together were examined.
Results: In all studies, the most common cause of urinary tract infections in both genders and all age groups is E. coli” and its frequency was reported as between 50% and 75%. Considering the antibiotic resistances, it was determined that Ampicillin, Sulfamethoxazole-trimethoprim, Ciprofloxacin, Amoxicillin-Clavulanic acid were the antibiotics with the highest resistance; Meropenem, Imipenem, Amikacin, Fosfomycin, Nitrofurantoin were found to be the antibiotics with the lowest resistance.
Conclusions: It is important to provide effective treatment for urinary tract infections, which are among the most common infections in our country and in the world, and E. coli, which is the most common cause of urinary tract infections. Resistance rates for E. coli may vary by region and may vary from year to year. Due to the development of high resistance to sulfamethoxazole-trimethoprim, ciprofloxacin and beta-lactam group antibiotics, which are frequently used in current treatments, and the increase in this resistance over time, especially revising empirical treatments with antibiotics with low resistance rates, studying antibiograms for treatment, and informing about conscious antibiotic consumption will increase the success of the treatment. It is expected to increase and prevent the increasing antibiotic resistance.
Cite this Article As : Aydın FN, Özdemir M. İdrar Yolu Enfeksiyonlarında Escherichia coli Sıklığı ve Antibiyotik Direnci: Bir Sistematik Derleme. Mev Med Sci. 2024; 4(3): 143-147

Conflict of interest : The authors declare that they have no conflict of interest.

This article is published under the CC BY-NC 4.0 license.
Mevlana Tıp Bilimleri
2024, Vol4, Issue3
E-ISSN: 2757-976X
Received : , Accepted : , Published Online :

References

  1. 1. Tanrıverdi Çaycı Y, Karacan G, Yoosefi M, Gür Vural D, Bilgin K, Bırıncı A. Çocuklarda İdrar Kültüründen İzole Edilen Gram Negatif Bakterilerin Ve Antibiyotik Duyarlılıklarının Retrospektif Olarak Değerlendirilmesi. Ahi Evran Medical Journal. Published Online January 20, 2022. Doi:10.46332/Aemj.957515
  2. 2. Ayhan M, Kalem Ak, Hasanoğlu İ, Kayaaslan B, Güner R. Evaluation Of Urinary Tract İnfections And Causative Agents İn Geriatric Patients. Turk Hijyen Ve Deneysel Biyoloji Dergisi. 2022;79(1):115-122. Doi:10.5505/Turkhijyen.2022.19971
  3. 3. Anggelia V, Oktavia C, Sutrisno H, Indita H. Pola Mikroba Dan Sensitivitasnya Terhadap Antibiotik Pada Pasien Dengan Infeksi Saluran Kemih Di Rsud Prof. Dr. W.Z. Johannes, Kupang Periode Januari-Desember 2017. Intisari Sains Medis. 2020;11(1):382. Doi:10.15562/İsm.V11i1.474
  4. 4. Nicolle Le, Evans G, Laverdieve M, Phillips P, Quan C, Rotstein C. Complicated Urinary Tract İnfection İn Adults. The Canadian Journal Of Infectious Diseases & Medical Microbiology. 2005;16(6):349. Doi:10.1155/2005/385768
  5. 5. Duane S, Beecher C, Vellinga A, Et Al. A Systematic Review Of The Outcomes Reported İn The Treatment Of Uncomplicated Urinary Tract İnfection Clinical Trials. Jac Antimicrob Resist. 2022;4(2). Doi:10.1093/Jacamr/Dlac025
  6. 6. Klein Rd, Hultgren Sj. Urinary Tract İnfections: Microbial Pathogenesis, Host–Pathogen İnteractions And New Treatment Strategies. Nature Reviews Microbiology 2020 18:4. 2020;18(4):211-226. Doi:10.1038/S41579-020-0324-0
  7. 7. Teker B, Sever N, Garashova D. Yaş Ve Cinsiyetin Üriner Sistem Enfeksiyonu Etkeni Escherichia Coli Kökenlerindeki Antibiyotik Direncine Etkisi. Online Türk Sağlık Bilimleri Dergisi. Published Online May 15, 2021. Doi:10.26453/Otjhs.936270
  8. 8. Bekis Bozkurt H, Balkan Çe. Çocuklarda İdrar Yolu Enfeksiyonlarında Antibiyotik Direnç Dağılımı; Beş Yıllık Bir Değerlendirme. Journal Of Pediatric Infection. 2020;14(3):146-153. Doi:10.5578/Ced.69308
  9. 9. Uslu M, Bağcıoğlu M, Tekdoğan Üy, Kocaaslan R, Çeçen K. Epidemology And Antibiotic Resistance Of Urinary Tract Infection İn The Kars Region. Kafkas Journal Of Medical Sciences. 2019;9(2):90-96. Doi:10.5505/Kjms.2019.26937
  10. 10. Warzecha D, Pietrzak B, Urban A, Wielgoś M. How To Avoid Drug Resistance During Treatment And Prevention Of Urinary Tract İnfections. Prz Menopauzalny. 2021;20(4):217. Doi:10.5114/Pm.2021.111715
  11. 11. İclal Bayhan G, Erdoğan Ö, Sami Ulus Kadın Doğum Sb, Sağlığı Ve Hastalıkları Eğitim Araştırma Hastanesi Ç, Nefroloji Bölümü Ç. İdrar Yolu Enfeksiyonu Geçiren 472 Hastanın Retrospektif Değerlendirilmesi Retrospectıve Evaluatıon Of 472 Chıldren Wıth Urınary Tract Infectıon. Vol 4.; 2010.
  12. 12. Gülsün S, Göktaş P. Tekrarlayan İdrar Yolu İnfeksiyonlarında Saptanan Risk Faktörleri.
  13. 13. Bilgehan Hakkı. Klinik Mikrobiyoloji Tanı. Barış Yayınları, Fakülteler Kitabevi; 1995.
  14. 14. Yilmaz R, Sağliği Hastaliklari Çv, Yard Doç Melike Emiroğlu D. Üriner Sistem Enfeksiyonlarında Antibiyotik Direncinin Araştırılması.
  15. 15. Mağden K. Microorganisms Isolated From Urine Cultures And Their Antibiotic Sensitivity. Kocaeli Medical Journal. 2021;10(2):16-21. Doi:10.5505/Ktd.2021.09581
  16. 16. Avcıoğlu F, Behçet M. Evaluation Of Resistance Rates Of Escherichia Coli Isolates Of Urinary Tract Infection To Various Antibiotics. Turk Mikrobiyol Cemiy Derg. 2020;50(3):172-177. Doi:10.5222/Tmcd.2020.172
  17. 17. Aşgın N, Eroğlu S, Kal Çakmaklıoğulları E. Which Antibiotics Should Be First Line Options For Empirical Treatment Of Urinary Tract Infections During Pregnancy? Ankem Dergisi. Published Online 2018. Doi:10.5222/Ankem.2018.1820
  18. 18. Coşkun B, Ayhan M. Evaluation Of Community-Acquired Lower Urinary Tract Infections. Journal Of Ankara University Faculty Of Medicine. 2022;75(3):388-393. Doi:10.4274/Atfm.Galenos.2022.76598
  19. 19. Çi̇lburunoğlu M, Kirişci Ö, Yerli̇kaya H, Uğurlu H, Aral M, Muratdağı G. Bir Üniversite Hastanesine Gönderilen İdrar Kültürlerinde Üreyen İzolatların Dağılımı Ve Antimikrobiyal Duyarlılık Profilinin İncelenmesi. Sakarya Medical Journal. Published Online November 21, 2020. Doi:10.31832/Smj.802643
  20. 20. Duran H, Çeken N, Kula Atik T. Antibiotic Resistance Rates Of Escherichia Coli And Klebsiella Pneumoniae Strains İsolated From Urine Culture: A Four-Year Analysis. Ankem Dergisi. Published Online 2020. Doi:10.5222/Ankem.2020.041
  21. 21. Karadeniz A, Hamidi Aa. Üropatojenlerde Antibiyotiklere Direnç Durumu: Sık Kullandığımız Ajanlar Etkili Mi? Uludağ Üniversitesi Tıp Fakültesi Dergisi. Published Online February 22, 2021. Doi:10.32708/Uutfd.854705
  22. 22. Kilinçel Ö, Elif Öztürk C, Ankarali H, Et Al. Diabetes Mellitus Ve Obezite Hastalarında Üriner Sistem Enfeksiyonu: Geriye Dönük Değerlendirme Urinary System Infection At Diabetes Mellitus And Obesity Patients: A Retrospective Evaluation. Vol 20.; 2018.
  23. 23. Kömürlüoğlu A, Aykaç K, Özsürekçi Y, Et Al. Antibiotic Resistance Distribution Of Gram-Negative Urinary Tract Infectious Agents: Single Center Experience. Turkish Journal Of Pediatric Disease. Published Online June 6, 2017. Doi:10.12956/Tjpd.2017.279
  24. 24. Yaşar Adem, Yaşar Belma, Akyüz Özkan Esra, Savcı Ünsal. Yozgat Yöresi Çocukluk Çağı İdrar Yolu Enfeksiyonuna En Sık Sebep Olan Etkenler Ve Antibiyotik Dirençleri. Bozok Tıp Dergisi. Published Online June 1, 2018. Doi:10.16919/Bozoktip.343112
  25. 25. Walker Mm, Roberts Ja, Rogers Ba, Harris Pna, Sime Fb. Current And Emerging Treatment Options For Multidrug Resistant Escherichia Coli Urosepsis: A Review. Antibiotics (Basel). 2022;11(12):1821. Doi:10.3390/Antıbıotıcs11121821
  26. 26. Kumar M N, Bhat S, Bhat K A, Saralaya V, Shenoy Mulki S. Characterization Of Virulence Factors And Antibiotic Resistance Pattern Of Uropathogenic Escherichia Coli Strains İn A Tertiary Care Center. F1000res. 2022;11:1163. Doi:10.12688/F1000research.125596.2
  27. 27. Gültepe B, Ceylan A, Ziya Doymaz M, Et Al. İdrar Kültürlerinden İzole Edilen Escherichia Coli Suşları’nın Antibiyotik Direnç Paterni. Duzce Medical Journal. 2014;16(1):53-55. Accessed December 27, 2022. Https://Dergipark.Org.Tr/En/Pub/Dtfd/İssue/48289/611398
  28. 28. Sa Lam Hs, Ö Ütlü A, Demiray V, Uz Karabay O. The Role Of Escherıchıa Colı’s In Communıty Acquıred Urınary Infectıons And Developıng Antıbıotıc Resıstance Üriner Enfeksiyonlarda Toplum Kökenli Escherichia Coli’ Nin Yeri Ve Gelişen Antibiyotik Direnci. Nobel Med. 2012;8(1):67-71.
  29. 29. Gültepe B, Ceylan A, Ziya Doymaz M, Et Al. Meryem Iraz. Düzce Tıp Fakültesi Dergisi. 2014;16(1):53-55. Accessed December 27, 2022. Www.Tipdergi.Duzce.Edu.Tr
  30. 30. Kowalska-Krochmal B, Mączyńska B, Rurańska-Smutnicka D, Et Al. Assessment Of The Susceptibility Of Clinical Gram-Negative And Gram-Positive Bacterial Strains To Fosfomycin And Significance Of This Antibiotic İn Infection Treatment. Pathogens. 2022;11(12):1441. Doi:10.3390/Pathogens11121441
  31. 31. Çetin H, Öktem F, Örmeci Ar, Yorgancıgil B, Yaylı G. Çocukluk Çağı İdrar Yolu Enfeksiyonlarında Escherichia Coli Ve Antibiyotik Direnci. Sdu Medical Faculty Journal. 2009;13(2):12-16. Doi:10.17343/Sdutfd.91956